CHAPTER 10 Ferrets
Agent | Dosage | Comments |
---|---|---|
Amikacin | 8-16 mg/kg SC, IM, IV divided q8-24h65,100 | Potentially ototoxic and nephrotoxic |
10-15 mg/kg SC, IM q12h11 | ||
Amoxicillin | — | Can use with metronidazole and bismuth subsalicylate for Helicobacter |
20 mg/kg PO, SC q12h38 | Helicobacter | |
30 mg/kg PO q8h29 × 21 days | ||
Amoxicillin/clavulanic acid (Clavamox, Pfizer) | 12.5 mg/kg PO q12h13 | |
13-25 mg/kg PO q8-12h38 | ||
Amphotericin B | 0.4-0.8 mg/kg IV q7d10 | Blastomycosis; monitor for azotemia; total dose 7-25 mg |
Ampicillin | 5-30 mg/kg SC, IM, IV q8-12h11,63 | |
Azithromycin | 5 mg/kg PO q24h77 | |
Cefadroxil | 15-20 mg/kg PO q12h13 | |
Cephalexin | 15-25 mg/kg PO q12h13 | |
15-30 mg/kg PO q8h38 | ||
Cephaloridine | 10-25 mg/kg SC, IM q24h × 5-7 days89 | Dermatitis |
Chloramphenicol | 25-50 mg/kg PO q12h13 | |
30-50 mg/kg SC, IM, IV q12h11,17 | ||
50 mg/kg PO, SC, IM, IV q12h37,38 | 14-day minimum for proliferative bowel disease37,38 | |
Ciprofloxacin (Cipro, Bayer) | — | Mix 500 mg tablet in 10 mL water (50 mg/mL) |
5-15 mg/kg PO q12h13 | Flavor for improved acceptance | |
10-30 mg/kg PO q24h17 | ||
Clarithromycin | 12.5 mg/kg PO q8-12h × 14 days50,56 | Helicobacter; use with ranitidine bismuth citrate |
50 mg/kg PO q24h or divided q12h × 14 days63 | Helicobacter; use with omeprazole (or ranitidine) and metronidazole | |
Clindamycin | 5.5-10 mg/kg PO q12h13 | Anaerobic infections; bone and dental disease |
12.5 mg/kg PO q12h102 | Toxoplasmosis | |
Cloxacillin | 10 mg/kg PO, IM, IV q6h10 | |
Enrofloxacin (Baytril, Bayer) | 5-10 mg/kg PO, SC, IM q12h13 | IM for short term (generally 1 injection); injectable form can be given PO in palatable liquid;13 liquid for PO can also be compounded |
8.5 mg/kg PO q24h or divided q12h50 | Can be used with bismuth subsalicylate for Helicobacter | |
10-20 mg/kg PO, SC, IM q12h100 | ||
10-30 mg/kg PO, SC, IM q24h86 | ||
Erythromycin | 10 mg/kg PO q6h10 | |
220 g/ton feed27 | Controlling Campylobacter diarrhea in large groups | |
Gentamicin | 2 mg/kg PO q12h × 10-14 days20 | Parenteral form can be given PO; proliferative colitis that is nonresponsive to chloramphenicol11,20 |
2-4 mg/kg SC, IM, IV q12h13 | If given IV, dilute with saline and administer over 20 min | |
5 mg/kg SC, IM q24h17 | ||
Griseofulvin | 25 mg/kg PO q1265-24h38 | Refractory dermatomycosis; use with lime-sulfur dips q7d38 |
Ketoconazole | 10-30 mg/kg PO q8h10 | |
10-30 mg/kg PO q12-24h100 | ||
10-50 mg/kg PO q12-24h51 | ||
Lime sulfur | Dip q7d38 | Dermatomycosis; see griseofulvin |
Lincomycin | 11 mg/kg PO q8h13 | |
Metronidazole | — | Anaerobic infections; can use with amoxicillin and bismuth subsalicylate for Helicobacter |
15-20 mg/kg PO q12h11 | ||
20 mg/kg PO q12h38,39 | ||
50 mg/kg PO q24h17 | ||
Neomycin | 10-20 mg/kg PO q6h10,17 | Potential nephrotoxicity and neuromuscular blockage |
Netilmicin (Netromycin, Schering) | 6-8 mg/kg SC, IM, IV q24h47 | Severe staphylococcal infections |
Oxytetracycline | 20 mg/kg PO q8h10,13,17 | |
Penicillin G (sodium or potassium) | 20,000 U/kg IM q12h51 | |
40,000-44,000 U/kg SC,65 IM q24h10,11,13 | ||
Pentamidine isethionate | 3-4 mg/kg SC q48h42 | Pneumocystis pneumonia |
Sulfadimethoxine | 25 mg/kg PO, SC, IM q24h13 | |
30-50 mg/kg PO q12-24h17 | ||
Sulfamethazine | 1-5 mg/mL drinking water62 | |
Sulfasoxazole | 50 mg/kg PO q8h13 | |
Tetracycline | 20 mg/kg PO q8h17 | |
25 mg/kg PO q12h10 | ||
Trimethoprim/sulfa | 5 mg/kg PO q24h31 | Pyelonephritis |
15 mg/kg IV q12h8 | ||
15-30 mg/kg PO, SC q12h38 | Dosage amount of combined drugs | |
Tylosin (Tylan, Elanco) | 5-10 mg/kg IM, IV q12h17 | |
10 mg/kg PO, SC q8-12h13,17,63 |
Agent | Dosage | Comments |
---|---|---|
Amitraz (Mitaban, Upjohn) | Topical to affected area q7-14d × 3-6 treatments61,63 | Demodecosis; use full concentration |
0.0125% solution q7d × 3 treatments then 0.0375% q7d × 3 treatments69 | Demodecosis secondary to other illness | |
Amprolium | 19 mg/kg PO q24h13 | Coccidiosis |
100 mg/kg PO in food or water for 7 days42 | Isospora | |
Carbaryl powder (5%) | Topical q7d × 3-6 treatments13 | Ectoparasites |
Decoquinate | 0.5 mg/kg PO for at least 2 weeks77 | Coccidiosis, larger groups of ferrets |
Fenbendazole | 20 mg/kg PO q24h × 5 days62 | |
50 mg/kg PO q24h × 30 days1 | Mesocestoides infection | |
Fipronil (Frontline, Merial) | 1 pump of spray or ⅕-½ of cat pipette topical q60d61 | Flea adulticide |
0.2-0.4 mL topically q30d100 | ||
Imidacloprid (Advantage, Bayer) | 1 cat dose divided onto 2-3 spots along dorsum q30d61 | Flea adulticide |
0.1 mL topically q30d100 | Use small cat/kitten vial | |
0.4 mL topically q30d51 | ||
Imidacloprid/moxidectin (Advantage Multi, Bayer) | 1.9-3.3 μg/kg topically q30d77 | Heartworm prevention |
Ivermectin | 0.05 mg/kg PO q30d38,94 | Heartworm preventative; adminster 1 mo before and continue to 2 mo after possible mosquito exposure |
0.05 mg/kg PO q30d until negative testing97 | Recommended treatment for heartworms; give prednisolone (1 mg/kg/d) concurrently | |
0.05 mg/kg PO, SC26,94 | Heartworm microfilaricide; 3-4 wk postadulticide treatment | |
0.05-0.3 mg/kg PO q24h for 1 mo after negative skin scraping8 | Demodecosis | |
0.055 mg/ferret PO q30d38 | Heartworm preventative (Heartgard, Merial); use small cat dose | |
0.2-0.5 mg/kg SC q14d × 3 treatments38 | Sarcoptic mange | |
0.4 mg/kg PO, SC, repeat in 14-28 days38,83 | Ear mites, ticks | |
0.5-1 mg/kg in ears, repeat in 14 days13,38 | Ear mites; half dose in each ear; treat cats and dogs in house concurrently | |
Lime sulfur | Dip 1:40 dilution q7d × 6 wk100 | Demodectic mange26 |
Lufenuron (Program, Novartis) | 30-45 mg/kg PO q30d47 | Flea larvicide |
Mebendazole | 50 mg/kg PO q12h × 2 days42 | Nematodes |
Melarsomine dihydrochloride (Immiticide, Merial) | 2.5 mg/kg IM once, repeat in 30 days with 2 treatments 24 hr apart13 | Heartworm adulticide; less commonly used; use prednisone (1 mg/kg q24h × 4 mo) following treatment |
Metronidazole | 15-20 mg/kg PO q12h × 14 days10 | Gastrointestinal protozoa |
Milbemycin oxime (Interceptor, Novartis) | 1.15-2.33 mg/kg PO q30d91 | Heartworm preventative |
Moxidectin | 0.1 mL SC97 | Heartworm treatment (single dose) or prevention every 6 mo |
0.17 mg SC once77 | Heartworm adulticide | |
Paramomycin | 165 mg/kg PO q12h × 5d77 | Cryptosporidiosis; possible treatment; use with caution, severe renal disease possible |
Piperazine | 50-100 mg/kg PO q14d13 | Intestinal nematodes |
Praziquantel (Droncit, Bayer) | 5-10 mg/kg PO, SC, repeat in 1065-14d10 | Cestodes |
25 mg/kg PO × 3d77 | Trematodes | |
Pyrantel pamoate | 4.4 mg/kg PO, repeat in 14 days13 | |
Pyrethrins | Topical q7d prn61 | Fleas; use products safe for puppies and kittens |
Pyrimethamine | 0.5 mg/kg PO q12h42 | Toxoplasmosis; antiprotozoal |
Selamectin (Revolution, Pfizer) | 6-10 mg/kg topically62,63 | Ectoparasites (fleas, lice, most mites except Demodex); doses of up to 10-12 mg/kg have also been recommended |
15 mg topically q30d21 | Ear mites, fleas | |
18 mg/kg topically77 | Heartworm prevention | |
Sulfadimethoxine | 20-50 mg/kg PO q24h9 | Coccidia |
50 mg/kg PO, then 25 mg/kg q24h × 9 days10 | ||
Thiabendazole/dexamethasone/neomycin (Tresaderm, Merial) | 2 drops in each ear q24h × 7 days, off 7 days, on 7 days73 | Ear mites |
Agent | Dosage | Comments |
---|---|---|
Acepromazine | — | See ketamine for combination |
0.1-0.25 mg/kg SC, IM10,24 | Preanesthetic; light sedation | |
0.2-0.5 mg/kg SC, IM24 | Tranquilization | |
Alphaxalone/alphadalone (Saffan, Glaxovet) | 6-8 mg/kg IM55 | Anesthesia; used mostly in laboratory situations; not available in the United States |
8-12 mg/kg IV15 | ||
Atipamezole (Antisedan, Pfizer) | 0.4 mg/kg IM19 | Dexmedetomidinea and medetomidinea reversal; give same volume SC, IV, IP as medetomidine or dexmedetomidine (5× medetomidine or 10× dexmedetomidine dose in mg) |
1 mg/kg SC, IV, IP23 | ||
Atropine | 0.04-0.05 mg/kg SC, IM, IV22,35,38 | Preanesthetic; bradycardia; hypersalivation |
Bupivacaine | 1 mg/kg epidurally64 | Epidural anesthesia/analgesia |
1-1.5 mg/kg SC infiltrate45 | Local anesthesia; lasts several hours | |
Dexmedetomidinea (Dexdomitor, Orion) | 0.04-0.1 mg/kg IM64 | α2 agonist similar to medetomidine; not commonly used because of bradycardia and other side effects |
Diazepam | — | See ketamine for combinations |
0.5 mg/kg PO, IM, IV q6-8h76 | Smooth muscle relaxation in urethral obstruction cases | |
0.5-1 mg/kg/hr constant-rate infusion4 | Seizure control | |
≤1 mg/kg IM11 | Stimulates appetite | |
1 mg/animal IV38 | Seizure control; 1-2 boluses | |
1-1.5 mg/hr continuous IV38 | Status epilepticus control | |
1-2 mg/kg IM11,24 | Tranquilization; seizure control4 | |
Enflurane | 2% maintenance19 | Anesthesia |
Etomidate | 1 mg/kg IV45 | Induction and intubation of critically ill animal |
Fentanyl citrate/fluanisone (Hypnorm, Janssen) | 0.3 mg/kg IM19 | Anesthesia; not available in the United States |
Fentanyl/droperidol (Innovar-Vet, Schering Plough) | 0.15 mL/kg IM24 | Minor surgical procedures; deep sedation |
Glycopyrrolate | 0.01 mg/kg IM35 | Preanesthetic; bradycardia; hypersalivation |
Isoflurane | 5% induction; 2%-3% maintenance11 | Inhalant anesthetic of choice |
Ketamine | — | Ketamine combinations follow |
10-20 mg/kg IM24 | Tranquilization | |
≤20 mg/kg IM35 | Induction; higher doses may cause apnea | |
30-60 mg/kg IM24 | Anesthesia | |
Ketamine (K)/acepromazine (A) | (K) 20-35 mg/kg + (A) 0.2-0.35 mg/kg SC, IM38 | Anesthesia |
Ketamine (K)/diazepam (D) | (K) 10-20 mg/kg + (D) 1-2 mg/kg IM38 | Anesthesia; poor analgesia60 |
(K) 25-35 mg/kg + (D) 2-3 mg/kg IM10,60 | ||
0.1 mL/kg IV19 | Induction; will allow intubation with premedication; use equal volumes of (K) at 100 mg/mL and (D) at 5 mg/mL | |
Ketamine (K)/dexmedetomidine (D) | (K) 5 mg/kg IM + (D) 0.03 mg/kg IM87 | Medetomidine no longer commercially available; dexmedetomidine at half the dose of medetomidine may be effectivea |
Ketamine (K)/medetomidine (M) or dexmedetomidine (D)/butorphanol (B) | — | Medetomidine no longer commercially available; dexmedetomidine at half the dose of medetomidine may be effectivea |
(K) 5 mg/kg + (M) 0.08 mg/kg or (D) 0.04 mg/kg + (B) 0.1 mg/kg IM19 | Induction | |
Ketamine (K)/midazolam (M) | (K) 5-10 mg/kg + (M) 0.25-0.5 mg/kg IV63 | |
0.1 mL/kg IV19 | Induction; use equal volumes of (K) at 100 mg/mL and (M) at 5 mg/mL | |
Ketamine (K)/xylazine (X) | (K) 10-25 mg/kg + (X) 1-2 mg/kg IM38,60 | Anesthesia; avoid in sick animals;38 may result in cardiac arrhythmias60 |
Lidocaine | 1-2 mg/kg total SC45 | Local anesthesia; use 1-2% solution; lasts 15-30 min |
Midazolam (Versed, Roche) | — | See ketamine for combination |
0.25-0.3 mg/kg SC, IM45 | Mild sedation; premedication | |
Morphine | 0.1 mg/kg90 | Epidural anesthesia; see Table 10-4 for analgesia |
Naloxone (Narcan, Dupont) | 0.01-0.03 mg/kg IM, IV15 | Reversal of opioids; up to 1 mg/kg may be used55 |
0.04 mg/kg SC, IM, IV12 | ||
Pentobarbital | 1-2 mg/kg PO q12h13 | Seizure control; use oral elixir |
Propofol | 1-3 mg/kg IV53 | Induction |
2-5 mg/kg IV18,19 | Induction | |
5-8 mg/kg IV15 | ||
Sevoflurane | To effect63 | Anesthesia |
Thiopental (2%) | 8-12 mg/kg IV18,19 | Induction |
Tiletamine/zolazepam (Telazol, Fort Dodge) | 12-22 mg/kg IM74 | Minor surgical procedures at 22 mg/kg; recovery may be prolonged at higher doses; poor muscle relaxation; rarely indicated |
Xylazine | — | See ketamine for combination |
0.1-0.5 mg/kg SC, IM65 | Tranquilization; may cause hypotension, bradycardia, and arrhythmias; use with care in sick animals | |
Yohimbine (Yobine, Lloyd) | 0.2 mg/kg IV15 | Xylazine reversal |
0.5-1 mg/kg IM15,65,95 |
a Dexmedetomidine (0.5 mg/mL) is an α2 agonist that is the active optical enantiomer of racemic compound medetomidine; ½ the dose of medetomidine (1 mg/mL) but same volume; although the same effects would be expected as with medetomidine (not commercially available, but can be obtained through various compounding services), there is limited data on the efficacy and safety of dexmedetomidine in ferrets, and, to date, appears to have been seldom used clinically in ferrets; the effects of the v/v use of the two drugs may not be equivalent, so the dose of dexmedetomidine may need to be adjusted based on clinical response.
Agent | Dosage | Comments |
---|---|---|
Acetylsalicylic acid (aspirin) | 0.5-22 mg/kg PO q8-24h38 | Analgesia; antiinflammatory; antipyretic |
10-20 mg/kg PO q24h100 | ||
Buprenorphine | 12 μg/kg epidurallya | Epidural analgesia/anesthesia |
0.01-0.03 mg/kg SC, IM, IV q8-12h35,55 | Analgesia | |
0.01-0.05 mg/kg SC, IM,100 IV13 q8-12h | ||
Butorphanol | — | See ketamine (Table 10-3) for anesthetic combination |
0.05-0.5 mg/kg SC, IM q8-12h13,55 | Analgesia | |
0.1-0.5 mg/kg SC, IM, IV q4-6h12,15 | ||
Carprofen (Rimadyl, Pfizer) | 1 mg/kg PO q12-24h13 | Nonsteroidal, antiinflammatory; use caution in animals with gastritis or enteritis |
1-5 mg/kg PO q12-24h12 | ||
Fentanyl citrate | 1.25-5 μg/kg/hr IV via constant rate infusiona | Postoperative analgesia |
10-30 μg/kg/hr IV via constant rate infusiona | Perioperative analgesia, after loading dose of 5-10 μg/kg IV | |
Flunixin meglumine (Banamine, Schering) | 0.3 mg/kg PO, SC q24h13 | Nonsteroidal antiinflammatory; use caution in animals with gastritis or enteritis; use caution in using drug more than 5 days continuously; mix injectable form with palatable syrup for PO |
0.5-2 mg/kg SC, IV q12-24h35 | ||
Gabapentin | 3-5 mg/kg PO q8-24h64 | Neurotropic pain; may cause sedation at higher doses |
Hydromorphone | 0.1-0.2 mg/kg SC, IM, IV51 | Opioid |
Ibuprofen | 1 mg/kg PO q12-24h63 | Nonsteroidal antiinflammatory |
Ketamine | 0.1-0.4 mg/kg/hr IV via constant rate infusiona | Postoperative analgesia |
0.3-1.2 mg/kg/hr IV via constant rate infusiona | Perioperative analgesia after 2-5 mg/kg IV loading dose | |
Ketoprofen (Ketofen, Fort Dodge) | 1-3 mg/kg PO, SC, IM q24h65 | Nonsteroidal antiinflammatory; use caution with gastritis or enteritis or if using >5 days |
Meloxicam (Metacam, Boehringer Ingelheim) | 0.2 mg/kg PO, SC, IM q24h41,45 | Nonsteroidal antiinflammatory; monitor liver and kidney values |
Meperidine (Demerol, Winthrop-Breon) | 5-10 mg/kg SC, IM, IV q2-4h35 | Analgesia |
Morphine | 0.2-2 mg/kg IM15 | Analgesia |
0.5-5 mg/kg SC, IM q2-6h35 | ||
Nalbuphine (Nubain, Endo Labs) | 0.5-1.5 mg/kg IM, IV q2-3h35 | Analgesia |
Oxymorphone | 0.05-0.2 mg/kg SC, IM, IV q8-12h35,45 | Analgesia |
Pentazocine (Talwin, Sanofi Winthrop) | 5-10 mg/kg IM q4h35 | Analgesia |
Tramadol | 5 mg/kg PO q12-2445 | Anaglesia; synergistic with NSAIDs |
a M Hawkins. Personal communication. 2011.
Agent | Dosage | Comments |
---|---|---|
Aminophylline | 4 mg/kg PO, IM, IV q12h13 | Bronchodilator |
4.4-6.6 mg/kg PO, IM q12h38 | ||
Atenolol (Tenormin, ICI) | 3.125-6.25 mg/kg PO q24h49,75 | β-adrenergic blocker for hypertrophic cardiomyopathy |
6.25 mg/animal PO q24h13,93 | ||
Atropine | 0.02-0.04 mg/kg SC, IM13 | Bradycardia |
0.1 mg/kg IT70 | ||
Benazepril | 0.25-0.5 mg/kg PO q24h49,97 | Vasodilator; less nephrotoxic than enalapril |
Captopril (Capoten, Squibb) | ⅛ of 12.5 mg tablet/animal PO q48h38 | Vasodilator; starting dose, gradually increase to q12-24h; can cause lethargy |
Digoxin (Cardoxin, Evsco) | 0.005-0.01 mg/kg PO q12-24h13,83 | Positive inotrope for dilated cardiomyopathy; monitor serum levels |
0.01 mg/kg PO q12h, start at 75% lean BW38 | ||
Diltiazem (Cardizem, Marion Merrill Dow) | 1.5-7.5 mg/kg PO q12h13,92 | Calcium channel blocker for hypertrophic cardiomyopathy |
Doxapram | 1-2 mg/kg IV22 | Respiratory stimulant |
5-11 mg/kg IV10 | ||
Enalapril (Enacard, Merck) | 0.25-0.5 mg/kg PO q24-48h13,83,93 | Vasodilator for dilated cardiomyopathy; do not use with concurrent renal disease7 |
⅛ of 2.5 mg tablet/animal PO q24h38 | ||
Epinephrine | 0.02 mg/kg SC, IM, IV, IT79 | Cardiac arrest; anaphylactic reactions |
Furosemide | 1-4 mg/kg PO, SC, IM, IV q8-12h13 | Diuretic; use high dose in fulminate heart failure |
Nitroglycerin (2%) ointment (Nitrol, Savage) | 1/16-⅛ inch/animal q12-24h11 | Vasodilator for cardiomyopathy; apply to shaved inner thigh or pinna |
Pimobendan | 0.5 mg/kg q12h97 | Phosphodiesterase inhibitor; increases cardiac contractility with dilated cardiomyopathy or mitral valve disease |
0.625-1.25 mg/kg q12h49 | ||
Propranolol (Inderal, Wyeth-Ayerst) | 0.2-1 mg/kg PO q8-12h38 | β-blocker for hypertrophic cardiomyopathy; may cause lethargy, loss of appetite11 |
2 mg/kg PO, SC q12h10,11 | ||
Theophylline | 4.25 mg/kg PO q8-12h13 | Bronchodilator; use elixir |
Agent | Dosage | Comments |
---|---|---|
Anastrazole (Arimidex, Astrazeneca Pharmaceuticals) | 0.1 mg/kg PO q24h85,99 | Estrogen inhibitor; precursor hormones blocked by inhibition of aromatase enzyme; use until signs resolve then 7 days on, 7 days off, etc.; pregnant owners should avoid handling agent |
Bicalutamide (Casodex, Astrazeneca Pharmaceuticals) | 5 mg/kg PO q24h85,99 | Testosterone inhibitor; competitively inhibits androgen by binding to receptors in target tissues; use until clinical signs resolve then 7 days on, 7 days off, etc.; pregnant owners should avoid handling agent |
Deoxycorticosterone pivalate (DOCP) | 2 mg/kg IM q21d32 | Treatment of adrenal insufficiency following bilateral adrenalectomy |
Deslorelin (Suprelorin, Peptech Animal Health) | 4.7 mg implant SC98 | Treatment of adrenal disease; lasts 10-18 months; not available in the United States; must be imported |
Finasteride | 5 mg/kg PO q24h84 | Treatment of prostatic enlargement; for use with adrenal disease |
Flutamide (Eulexin, Schering) | 10 mg/kg PO q12-24h13,80 | Androgen inhibitor; reduces enlarged periurethral prostate tissue; lifetime treatment; associated with mammary tumors44 |
Leuprolide acetate | — | Long acting GnRH analog that may cause an initial stimulation then suppression of LH and FSH; palliative treatment of adrenal disease (will not resolve tumor); administer q28d until clinical signs regress, then treatment interval can be up to 6-8 wk; lifetime treatment; higher dosage may shrink prostate within 12-48 hr which may improve urine flow in cases of urethral obstruction; must be prepared in aliquots and frozen (although the effects of freezing on drug efficacy are questionable) until used; very expensive |
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |